Cancer Management and Research (Sep 2022)

miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer [Corrigendum]

  • Zhan T,
  • Zhu Q,
  • Han Z,
  • Tan J,
  • Liu M,
  • Liu W,
  • Chen W,
  • Chen X,
  • Chen X,
  • Deng J,
  • Tian X,
  • Huang X

Journal volume & issue
Vol. Volume 14
pp. 2671 – 2672

Abstract

Read online

Zhan T, Zhu Q, Han Z, et al. Cancer Manag Res. 2020;12:1483–1492. The authors have advised Figure 4C on page 1490 is incorrect. Due to an error at the time of figure assembly Figure 4D and Figure 4C were inadvertently duplicated. The correct Figure 4 is shown below. Figure 4 miR-455-3p restrains Wnt/β-catenin signaling via TAZ. (A and B) Expression of β-catenin, Cyclin D and C-myc in pancreatic cancer cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector was detected by qPCR. (C and D) Western blot analysis of β-catenin, Cyclin D and C-myc in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector β-actin is used as loading control vs miR-455-3p mimics/mimic control group, miR-455-3p mimics/miR-455-3p mimics+TAZ group. *p <0.05, miR-455-3p mimics vs mimic control group, miR-455-3p mimics vs miR-455-3p mimics+TAZ group. The authors apologize for the error.

Keywords